Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20067054 | 0.89 | KMT2A (0.48) | MEN1KMT2ATSHRRECQLCA12 | |
| SCHEMBL12423819 | 0.87 | KMT2A (0.47) | MEN1KMT2ATSHRRECQLCYP1A2 | |
| SCHEMBL20067042 | 0.84 | MEN1 (0.42) | MEN1KMT2ATSHRRECQLCYP1A2 | |
| SCHEMBL20067046 | 0.83 | CASP2 (0.37) | MEN1KMT2ATSHRRECQLDNM1 | |
| SCHEMBL18174866 | 0.83 | KMT2A (0.43) | MEN1KMT2ATSHRRECQLCYP1A2 | |
| SCHEMBL19035553 | 0.83 | CYP1A2 (0.44) | MEN1KMT2ATSHRRECQLCYP1A2 | |
| SCHEMBL20067045 | 0.82 | MEN1 (0.35) | MEN1KMT2ATSHRRECQLCA12 | |
| SCHEMBL12461822 | 0.81 | RECQL (0.52) | MEN1KMT2ATSHRRECQLDNM1 | |
| SCHEMBL22414250 | 0.81 | TSHR (0.40) | MEN1KMT2ATSHRRECQLCYP1A2 | |
| SCHEMBL24727476 | 0.78 | TSHR (0.50) | MEN1KMT2ATSHRRECQLCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180108944-A1 | GRAPHENE COMPOUND AND MANUFACTURING METHOD THEREOF, ELECTROLYTE, AND POWER STORAGE DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180108944-A1 | GRAPHENE COMPOUND AND MANUFACTURING METHOD THEREOF, ELECTROLYTE, AND POWER STORAGE DEVICE | ILK, GK, KCNH3 | MEN1 4232/4885KMT2A 1311/4885TSHR 3831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.